University of Southern California
USC/Norris Comprehensive Cancer Center
If you are a patient, please contact The Doctors of USC at 800-USC-CARE.

Details for trial 0C-04-3


 
Description: Phase I Trial of Intravenous Fenretinide (4-HPR) for Patients with Hematologic Malignancies.
Status: Open
Randomized? No


Researchers  
Principal InvestigatorTitle
Ann MohrbacherM.D.

Data Management
NameTitle
Lori VergaraR.N.


You may participate in this study if:
(No criteria found)

You may not participate in this study if:
(No criteria found)

For further information on, or to sign up for this study, please contact the Clinical Investigation Support Office at (323) 865-0451 or the Principal Investigator noted above.